38 results
6-K
BYSI
BeyondSpring Inc
18 Mar 24
Current report (foreign)
8:30am
professional in scientific, translational, and strategic analysis aspects of R&D projects and pipeline assets, with nearly 25 years of industry experience
6-K
EX-99.1
BYSI
BeyondSpring Inc
26 Feb 24
Current report (foreign)
8:01am
Therapeutics, leverages a proprietary targeted protein degradation (TPD) drug discovery platform and has an initial R&D collaboration with Eli Lilly
6-K
EX-99.1
BYSI
BeyondSpring Inc
10 Jan 24
Current report (foreign)
3:00pm
degradation (TPD) drug discovery platform and has an initial R&D collaboration with Eli Lilly. Learn more by visiting https://beyondspringpharma.com
6-K
EX-99.1
BYSI
BeyondSpring Inc
18 Dec 23
BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements
4:31pm
subsidiary, SEED Therapeutics, leverages a proprietary targeted protein degradation (TPD) drug discovery platform and has an initial R&D collaboration
6-K
EX-99.1
yqpuwsoubtsz
30 Oct 23
Current report (foreign)
8:05am
6-K
EX-99.1
wmcjtkvz
4 Oct 23
BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements
4:00pm
6-K
EX-99.1
ajwldorfs4
23 Nov 22
BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements
4:30pm
6-K
EX-99.1
qkwblm6
30 Dec 21
Current report (foreign)
12:30pm
6-K
EX-99.1
0ghqfsbxab8gm8l8
10 Nov 21
BeyondSpring Appoints Commercial Leader Mark Santos to its Board of Directors
4:05pm
6-K
EX-99.1
o01 0kbjcb
10 Sep 21
Current report (foreign)
8:30am
6-K
EX-99.1
59r4niku 8myddgmf7o
26 Aug 21
BeyondSpring Announces Exclusive Commercialization and Co-development Agreement with Jiangsu Hengrui Pharmaceuticals for Plinabulin in Greater China
7:15am
6-K
snky1rk9889pyefus2
26 Aug 21
BeyondSpring Announces Exclusive Commercialization and Co-development Agreement with Jiangsu Hengrui Pharmaceuticals for Plinabulin in Greater China
7:15am
6-K
EX-99.1
skeard
4 Aug 21
Current report (foreign)
7:30am
6-K
EX-99.1
1g0vu6p
16 Jun 21
BeyondSpring Announces First Quarter 2021 Financial Results and Provides a Corporate Update
8:36am
6-K
EX-99.1
2778n4wxif56f96jg80y
18 Dec 20
BeyondSpring Announces the Appointment of Dr. Jeffrey Vacirca to its Board of Directors
6:01am
6-K
EX-99.1
h5lsq4f9deevavwc72
17 Nov 20
BeyondSpring Announces Third Quarter 2020 Financial Results and Provides Business Updates
8:06am